MAPT and Alzheimer disease: Additionally, post-mortem brain studies in AD show epigenetic changes, including a nuclear loss of the histone mark H3K4me3 accompanied by its progressive cytoplasmic accumulation, which occurs prior to detectable tau pathology and may contribute to the persistent inflammation characteristic during the early stages of disease progression (Mastroeni et al., 2015).